PF-07994525

An Open-Label Phase 1 Study to Evaluate PF-07994525 in Participants With Advanced Malignancies

More Information

Trial Status
Accepting patients
Trial Phase
Phase 1
Enrollment
120 patients (estimated)
Tags
KAT2 Inhibitor
Trial Type
Treatment
Last Update
SparkCures ID
2251
NCT Identifier
NCT07426757

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.